Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions.
van der Horst MZ, Meijer Y, de Boer N, Guloksuz S, Hasan A, Siskind D, Wagner E; CLOZIN consortium; Okhuijsen-Pfeifer C, Luykx JJ. van der Horst MZ, et al. Among authors: siskind d. Psychiatry Res. 2023 Dec;330:115539. doi: 10.1016/j.psychres.2023.115539. Epub 2023 Oct 11. Psychiatry Res. 2023. PMID: 37988817 Free article.
Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine.
Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, Frank E, Cordes J, Wölwer W, Winterer G, Gaebel W, Hajak G, Ohmann C, Verde PE, Rietschel M, Ahmed R, Honer WG, Siskind D, Malchow B, Strube W, Schneider-Axmann T, Falkai P, Hasan A. Wagner E, et al. Among authors: siskind d. Schizophr Res. 2019 Jun;208:370-376. doi: 10.1016/j.schres.2019.01.021. Epub 2019 Jan 29. Schizophr Res. 2019. PMID: 30704862 Clinical Trial.
Repetitive transcranial magnetic stimulation (rTMS) for schizophrenia patients treated with clozapine.
Wagner E, Honer WG, Sommer IE, Koops S, Blumberger DM, Daskalakis ZJ, Dlabac-De Lange JJ, Bais L, Knegtering H, Aleman A, Novak T, Klirova M, Slotema C, Brunelin J, Poulet E, Kujovic M, Cordes J, Wobrock T, Siskind D, Falkai P, Schneider-Axmann T, Hasan A. Wagner E, et al. Among authors: siskind d. World J Biol Psychiatry. 2021 Jan;22(1):14-26. doi: 10.1080/15622975.2020.1733080. Epub 2020 Mar 13. World J Biol Psychiatry. 2021. PMID: 32081071
Consensus statement on the use of clozapine during the COVID-19 pandemic.
Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Siskind D, et al. J Psychiatry Neurosci. 2020 Apr 3;45(4):200061. doi: 10.1503/jpn.200061. Online ahead of print. J Psychiatry Neurosci. 2020. PMID: 32242646 No abstract available.
Consensus statement on the use of clozapine during the COVID-19 pandemic.
Siskind D, Honer WG, Clark S, Correll CU, Hasan A, Howes O, Kane JM, Kelly DL, Laitman R, Lee J, MacCabe JH, Myles N, Nielsen J, Schulte PF, Taylor D, Verdoux H, Wheeler A, Freudenreich O. Siskind D, et al. J Psychiatry Neurosci. 2020 May 1;45(3):222-223. doi: 10.1503/jpn.200061. J Psychiatry Neurosci. 2020. PMID: 32297722 Free PMC article. No abstract available.
Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group.
Wagner E, Kane JM, Correll CU, Howes O, Siskind D, Honer WG, Lee J, Falkai P, Schneider-Axmann T, Hasan A; TRRIP Working Group. Wagner E, et al. Among authors: siskind d. Schizophr Bull. 2020 Dec 1;46(6):1459-1470. doi: 10.1093/schbul/sbaa060. Schizophr Bull. 2020. PMID: 32421188 Free PMC article.
261 results